Healthcare Sector Stocks
The Healthcare sector has a total of 1059 stocks, with a combined market cap of $8.39 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.72.
Market Cap
8.39T
Revenue
4.59T
Profits
201.11B
PE Ratio
41.72
Profit Margin
4.38%
Dividend Yield
0.43%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 949.70B | 2.24% | 3,472,924 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 564.11B | 1.13% | 5,464,729 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 381.10B | 0.56% | 5,407,981 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 352.79B | 1.57% | 5,602,085 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 302.33B | - | 14,754,581 | 65.77B |
| 6 | NVS | Novartis AG | 290.10B | - | 1,410,578 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 290.09B | - | 2,120,800 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 198.94B | - | 10,790,951 | 50.57B |
| 9 | AMGN | Amgen Inc. | 183.12B | - | 1,567,235 | 37.22B |
| 10 | GILD | Gilead Sciences, Inc. | 166.82B | - | 5,973,641 | 29.74B |
| 11 | TMO | Thermo Fisher Scientific Inc. | 166.59B | -0.24% | 1,686,092 | 45.20B |
| 12 | ISRG | Intuitive Surgical, Inc. | 155.16B | -0.39% | 2,010,239 | 10.58B |
| 13 | ABT | Abbott Laboratories | 152.25B | - | 9,519,417 | 45.13B |
| 14 | PFE | Pfizer Inc. | 147.62B | -0.19% | 22,320,030 | 63.32B |
| 15 | DHR | Danaher Corporation | 121.74B | - | 2,995,153 | 24.78B |
| 16 | BMY | Bristol-Myers Squibb Company | 121.42B | - | 6,489,774 | 48.48B |
| 17 | SYK | Stryker Corporation | 121.33B | - | 1,893,104 | 25.27B |
| 18 | CVS | CVS Health Corporation | 118.99B | - | 4,838,610 | 405.62B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 110.28B | - | 1,746,340 | 12.22B |
| 20 | SNY | Sanofi | 108.28B | -1.40% | 2,763,267 | 54.60B |
| 21 | GSK | GSK plc | 102.74B | - | 3,154,091 | 43.29B |
| 22 | MDT | Medtronic plc | 100.91B | 0.58% | 7,051,744 | 35.48B |
| 23 | MCK | McKesson Corporation | 92.09B | - | 2,323,958 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 87.42B | - | 1,110,247 | 76.39B |
| 25 | BSX | Boston Scientific Corporation | 85.88B | 1.10% | 11,739,977 | 20.61B |
| 26 | ELV | Elevance Health, Inc. | 85.71B | - | 1,090,599 | 200.42B |
| 27 | CI | The Cigna Group | 75.72B | - | 1,435,101 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 65.00B | - | 995,023 | 14.92B |
| 29 | COR | Cencora, Inc. | 53.49B | - | 2,144,726 | 328.68B |
| 30 | ARGX | argenx SE | 51.12B | - | 171,192 | 4.74B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 50.26B | - | 4,011,384 | 28.34B |
| 32 | EW | Edwards Lifesciences Corporation | 49.39B | - | 4,941,924 | 6.30B |
| 33 | MDLN | Medline Inc. | 48.62B | - | 43,070,555 | 29.14B |
| 34 | CAH | Cardinal Health, Inc. | 47.00B | - | 1,537,350 | 250.74B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 44.12B | - | 466,004 | 4.45B |
| 36 | HLN | Haleon plc | 40.94B | -0.32% | 6,951,674 | 14.85B |
| 37 | BDX | Becton, Dickinson and Company | 40.68B | - | 1,291,275 | 22.23B |
| 38 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.71B | - | 681,308 | 4.29B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 39.67B | -0.26% | 2,710,347 | 17.35B |
| 40 | HUM | Humana Inc. | 36.97B | - | 678,101 | 137.20B |
| 41 | ONC | BeOne Medicines AG | 34.49B | - | 190,918 | 5.70B |
| 42 | ZTS | Zoetis Inc. | 34.09B | - | 6,327,418 | 9.53B |
| 43 | WAT | Waters Corporation | 33.62B | - | 477,982 | 3.77B |
| 44 | ALC | Alcon Inc. | 33.07B | - | 2,002,954 | 10.63B |
| 45 | A | Agilent Technologies, Inc. | 32.49B | - | 2,036,584 | 7.07B |
| 46 | RVMD | Revolution Medicines, Inc. | 32.22B | - | 1,935,096 | - |
| 47 | RPRX | Royalty Pharma plc | 31.38B | - | 3,053,873 | 2.44B |
| 48 | RMD | ResMed Inc. | 30.18B | - | 1,095,752 | 5.54B |
| 49 | GEHC | GE HealthCare Technologies Inc. | 29.22B | - | 3,182,763 | 20.98B |
| 50 | CNC | Centene Corporation | 29.20B | - | 2,917,631 | 178.33B |
| 51 | NTRA | Natera, Inc. | 29.10B | - | 1,036,809 | 2.50B |
| 52 | BIIB | Biogen Inc. | 28.61B | - | 892,934 | 9.94B |
| 53 | IQV | IQVIA Holdings Inc. | 28.02B | - | 1,791,001 | 16.63B |
| 54 | DXCM | DexCom, Inc. | 27.82B | - | 6,727,437 | 4.82B |
| 55 | PHG | Koninklijke Philips N.V. | 26.39B | -0.74% | 1,001,816 | 20.34B |
| 56 | VEEV | Veeva Systems Inc. | 26.14B | - | 2,019,432 | 3.20B |
| 57 | UTHR | United Therapeutics Corporation | 24.13B | - | 281,045 | 3.17B |
| 58 | BNTX | BioNTech SE | 23.30B | - | 668,772 | 3.23B |
| 59 | INSM | Insmed Incorporated | 23.03B | - | 2,432,893 | 819.56M |
| 60 | WST | West Pharmaceutical Services, Inc. | 22.35B | - | 533,752 | 3.22B |
| 61 | MTD | Mettler-Toledo International Inc. | 22.29B | - | 134,510 | 4.09B |
| 62 | ILMN | Illumina, Inc. | 21.85B | - | 906,015 | 4.39B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.61B | - | 871,497 | 11.28B |
| 64 | ROIV | Roivant Sciences Ltd. | 21.55B | - | 5,874,375 | 8.26M |
| 65 | LH | Labcorp Holdings Inc. | 21.31B | - | 543,206 | 14.14B |
| 66 | STE | STERIS plc | 21.24B | - | 645,470 | 5.94B |
| 67 | INCY | Incyte Corporation | 19.41B | - | 879,786 | 5.36B |
| 68 | VTRS | Viatris Inc. | 19.39B | - | 7,362,139 | 14.56B |
| 69 | MRNA | Moderna, Inc. | 18.60B | - | 4,223,676 | 2.23B |
| 70 | ZBH | Zimmer Biomet Holdings, Inc. | 16.54B | - | 1,809,927 | 8.41B |
| 71 | GMAB | Genmab A/S | 16.43B | - | 1,205,430 | 3.90B |
| 72 | GH | Guardant Health, Inc. | 15.77B | - | 2,819,648 | 1.08B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 15.76B | - | 758,794 | 3.10B |
| 74 | ASND | Ascendis Pharma A/S | 15.34B | - | 450,896 | 998.25M |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 15.05B | - | 550,092 | 4.44B |
| 76 | THC | Tenet Healthcare Corporation | 14.97B | - | 1,006,005 | 21.46B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 13.54B | - | 1,826,453 | 579.96M |
| 78 | SOLV | Solventum Corporation | 13.31B | - | 1,629,332 | 8.26B |
| 79 | SNN | Smith & Nephew plc | 13.06B | - | 1,038,644 | 6.16B |
| 80 | PEN | Penumbra, Inc. | 12.93B | - | 508,565 | 1.45B |
| 81 | SMMT | Summit Therapeutics Inc. | 12.90B | - | 6,890,998 | - |
| 82 | RGC | Regencell Bioscience Holdings Limited | 12.76B | - | 143,746 | - |
| 83 | DVA | DaVita Inc. | 12.74B | - | 629,238 | 13.84B |
| 84 | EXEL | Exelixis, Inc. | 12.61B | - | 1,543,919 | 2.38B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.49B | - | 1,579,206 | 1.06B |
| 86 | MEDP | Medpace Holdings, Inc. | 12.36B | - | 233,228 | 2.68B |
| 87 | COO | The Cooper Companies, Inc. | 12.20B | - | 1,536,740 | 4.15B |
| 88 | AXSM | Axsome Therapeutics, Inc. | 12.14B | - | 674,623 | 708.24M |
| 89 | BTSG | BrightSpring Health Services, Inc. | 12.03B | - | 1,447,457 | 13.65B |
| 90 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.93B | - | 160,813 | 1.13B |
| 91 | FMS | Fresenius Medical Care AG | 11.77B | - | 390,103 | 22.32B |
| 92 | ALGN | Align Technology, Inc. | 11.72B | - | 844,547 | 4.10B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.65B | - | 723,653 | 3.58B |
| 94 | GMED | Globus Medical, Inc. | 11.51B | - | 1,808,899 | 3.10B |
| 95 | ELAN | Elanco Animal Health Incorporated | 10.85B | - | 5,828,949 | 4.89B |
| 96 | RVTY | Revvity, Inc. | 10.82B | - | 942,863 | 2.90B |
| 97 | PODD | Insulet Corporation | 10.73B | - | 949,143 | 2.90B |
| 98 | ABVX | ABIVAX Société Anonyme | 10.68B | -1.64% | 1,178,975 | 5.67M |
| 99 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.56B | - | 1,401,643 | 622.01M |
| 100 | BMRN | BioMarin Pharmaceutical Inc. | 10.45B | - | 2,438,349 | 3.24B |
| 101 | CYTK | Cytokinetics, Incorporated | 10.45B | - | 1,111,299 | 105.82M |
| 102 | EHC | Encompass Health Corporation | 10.41B | - | 668,197 | 6.07B |
| 103 | ENSG | The Ensign Group, Inc. | 9.97B | - | 447,117 | 5.27B |
| 104 | BAX | Baxter International Inc. | 9.91B | - | 7,219,918 | 11.32B |
| 105 | MOH | Molina Healthcare, Inc. | 9.59B | - | 542,594 | 43.10B |
| 106 | PRAX | Praxis Precision Medicines, Inc. | 9.58B | - | 249,965 | 7.46M |
| 107 | UHS | Universal Health Services, Inc. | 9.55B | - | 1,236,516 | 17.76B |
| 108 | MASI | Masimo Corporation | 9.36B | - | 677,255 | 1.56B |
| 109 | ICLR | ICON Public Limited Company | 8.92B | - | 383,746 | 8.10B |
| 110 | KRYS | Krystal Biotech, Inc. | 8.83B | - | 162,219 | 417.30M |
| 111 | HSIC | Henry Schein, Inc. | 8.45B | - | 1,023,122 | 13.38B |
| 112 | TEM | Tempus AI, Inc. | 8.29B | -0.67% | 4,302,519 | 1.36B |
| 113 | HALO | Halozyme Therapeutics, Inc. | 8.10B | - | 1,197,518 | 1.51B |
| 114 | NUVL | Nuvalent, Inc. | 8.07B | - | 568,636 | - |
| 115 | CRL | Charles River Laboratories International, Inc. | 7.72B | - | 588,606 | 4.03B |
| 116 | BIO | Bio-Rad Laboratories, Inc. | 7.70B | - | 273,238 | 2.59B |
| 117 | IBRX | ImmunityBio, Inc. | 7.56B | - | 17,939,227 | 140.98M |
| 118 | TECH | Bio-Techne Corporation | 7.55B | - | 2,535,154 | 1.21B |
| 119 | HQY | HealthEquity, Inc. | 7.44B | - | 836,982 | 1.31B |
| 120 | ATR | AptarGroup, Inc. | 7.42B | - | 405,783 | 3.87B |
| 121 | QGEN | Qiagen N.V. | 7.27B | - | 1,197,046 | 2.10B |
| 122 | GKOS | Glaukos Corporation | 7.06B | - | 2,709,884 | 551.35M |
| 123 | IMVT | Immunovant, Inc. | 7.01B | - | 1,685,458 | - |
| 124 | BRKR | Bruker Corporation | 6.96B | - | 1,506,457 | 3.46B |
| 125 | GRFS | Grifols, S.A. | 6.88B | - | 379,991 | 8.58B |
| 126 | PCVX | Vaxcyte, Inc. | 6.83B | - | 1,328,277 | - |
| 127 | OSCR | Oscar Health, Inc. | 6.82B | - | 5,321,104 | 13.30B |
| 128 | CELC | Celcuity Inc. | 6.74B | - | 661,191 | - |
| 129 | LNTH | Lantheus Holdings, Inc. | 6.71B | - | 2,020,676 | 1.55B |
| 130 | RGEN | Repligen Corporation | 6.49B | - | 722,882 | 763.34M |
| 131 | KYMR | Kymera Therapeutics, Inc. | 6.49B | - | 549,372 | 51.48M |
| 132 | CORT | Corcept Therapeutics Incorporated | 6.46B | - | 536,139 | 769.10M |
| 133 | SYRE | Spyre Therapeutics, Inc. | 6.43B | - | 574,925 | - |
| 134 | PTGX | Protagonist Therapeutics, Inc. | 6.38B | - | 393,915 | 74.06M |
| 135 | CNTA | Centessa Pharmaceuticals plc | 6.15B | - | 707,486 | 15.00M |
| 136 | ALKS | Alkermes plc | 6.13B | - | 907,753 | 1.56B |
| 137 | APGE | Apogee Therapeutics, Inc. | 6.08B | - | 338,435 | - |
| 138 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.02B | - | 479,070 | 217.17M |
| 139 | MIRM | Mirum Pharmaceuticals, Inc. | 6.01B | - | 453,055 | 569.61M |
| 140 | PACS | PACS Group, Inc. | 5.97B | - | 955,264 | 5.43B |
| 141 | TFX | Teleflex Incorporated | 5.88B | - | 648,561 | 2.13B |
| 142 | CHE | Chemed Corporation | 5.81B | - | 162,103 | 2.54B |
| 143 | SRRK | Scholar Rock Holding Corporation | 5.77B | - | 852,226 | - |
| 144 | PTCT | PTC Therapeutics, Inc. | 5.71B | - | 715,145 | 827.11M |
| 145 | BLCO | Bausch + Lomb Corporation | 5.68B | - | 264,078 | 5.21B |
| 146 | CGON | CG Oncology, Inc. | 5.67B | - | 652,816 | 5.07M |
| 147 | COGT | Cogent Biosciences, Inc. | 5.58B | - | 1,966,916 | - |
| 148 | AVTR | Avantor, Inc. | 5.54B | - | 7,217,634 | 6.55B |
| 149 | TGTX | TG Therapeutics, Inc. | 5.51B | - | 1,358,470 | 700.35M |
| 150 | HIMS | Hims & Hers Health, Inc. | 5.50B | -1.08% | 14,780,566 | 2.37B |
| 151 | LEGN | Legend Biotech Corporation | 5.46B | - | 2,049,729 | 1.14B |
| 152 | LQDA | Liquidia Corporation | 5.42B | - | 974,166 | 288.07M |
| 153 | BLTE | Belite Bio, Inc | 5.40B | - | 107,738 | - |
| 154 | XENE | Xenon Pharmaceuticals Inc. | 5.24B | - | 969,842 | 7.50M |
| 155 | STVN | Stevanato Group S.p.A. | 4.92B | - | 218,679 | 1.39B |
| 156 | CRSP | CRISPR Therapeutics AG | 4.86B | - | 1,550,761 | 4.10M |
| 157 | DNTH | Dianthus Therapeutics, Inc. | 4.73B | - | 469,757 | 1.34M |
| 158 | LGND | Ligand Pharmaceuticals Incorporated | 4.60B | - | 368,252 | 274.48M |
| 159 | SHC | Sotera Health Company | 4.47B | - | 2,312,968 | 1.19B |
| 160 | CAI | Caris Life Sciences, Inc. | 4.40B | - | 1,808,978 | 907.29M |
| 161 | RDNT | RadNet, Inc. | 4.28B | - | 423,081 | 2.14B |
| 162 | HNGE | Hinge Health, Inc. | 4.28B | - | 1,306,185 | 646.34M |
| 163 | MANE | Veradermics, Incorporated | 4.25B | - | 278,733 | - |
| 164 | NAMS | NewAmsterdam Pharma Company N.V. | 4.14B | - | 583,591 | 22.57M |
| 165 | TVTX | Travere Therapeutics, Inc. | 4.13B | - | 803,425 | 536.20M |
| 166 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.10B | - | 383,825 | 754.05M |
| 167 | LIVN | LivaNova PLC | 4.06B | - | 418,006 | 1.43B |
| 168 | AMRX | Amneal Pharmaceuticals, Inc. | 3.96B | - | 953,578 | 3.05B |
| 169 | BLLN | BillionToOne, Inc. | 3.95B | - | 374,577 | 354.54M |
| 170 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.88B | - | 702,432 | 18.07M |
| 171 | IRTC | iRhythm Holdings, Inc. | 3.83B | - | 462,964 | 787.85M |
| 172 | MMSI | Merit Medical Systems, Inc. | 3.83B | - | 449,466 | 1.54B |
| 173 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | - | 1,993,234 | 596.96M |
| 174 | NVST | Envista Holdings Corporation | 3.81B | - | 2,759,857 | 2.81B |
| 175 | TWST | Twist Bioscience Corporation | 3.77B | - | 1,617,926 | 409.48M |
| 176 | WAY | Waystar Holding Corp. | 3.75B | - | 2,132,874 | 1.16B |
| 177 | ORKA | Oruka Therapeutics, Inc. | 3.66B | - | 1,101,798 | - |
| 178 | DOCS | Doximity, Inc. | 3.65B | - | 3,475,644 | 644.86M |
| 179 | ACAD | ACADIA Pharmaceuticals Inc. | 3.61B | - | 1,376,987 | 1.10B |
| 180 | VCYT | Veracyte, Inc. | 3.59B | - | 1,398,669 | 541.74M |
| 181 | VKTX | Viking Therapeutics, Inc. | 3.59B | - | 1,222,922 | - |
| 182 | OGN | Organon & Co. | 3.53B | - | 2,121,163 | 6.16B |
| 183 | EWTX | Edgewise Therapeutics, Inc. | 3.52B | - | 681,407 | - |
| 184 | ERAS | Erasca, Inc. | 3.50B | - | 2,494,052 | - |
| 185 | ALHC | Alignment Healthcare, Inc. | 3.38B | - | 2,803,608 | 4.26B |
| 186 | MMED | MiniMed Group, Inc. | 3.33B | - | 696,299 | 2.99B |
| 187 | ICUI | ICU Medical, Inc. | 3.33B | - | 306,468 | 2.16B |
| 188 | OPCH | Option Care Health, Inc. | 3.29B | - | 2,480,175 | 5.67B |
| 189 | CON | Concentra Group Holdings Parent, Inc. | 3.24B | - | 887,346 | 2.23B |
| 190 | TLX | Telix Pharmaceuticals Limited | 3.23B | - | 258,615 | 803.79M |
| 191 | BKD | Brookdale Senior Living Inc. | 3.18B | - | 2,161,340 | 3.00B |
| 192 | WRBY | Warby Parker Inc. | 3.08B | - | 1,473,846 | 890.57M |
| 193 | NHC | National HealthCare Corporation | 3.06B | - | 132,805 | 1.53B |
| 194 | ITGR | Integer Holdings Corporation | 3.03B | - | 365,277 | 1.86B |
| 195 | TXG | 10x Genomics, Inc. | 3.01B | - | 3,798,904 | 638.78M |
| 196 | HAE | Haemonetics Corporation | 2.98B | - | 1,036,866 | 1.33B |
| 197 | DNLI | Denali Therapeutics Inc. | 2.96B | - | 3,557,141 | - |
| 198 | RLAY | Relay Therapeutics, Inc. | 2.95B | - | 5,355,352 | 10.68M |
| 199 | RCUS | Arcus Biosciences, Inc. | 2.95B | - | 516,535 | 236.00M |
| 200 | TNGX | Tango Therapeutics, Inc. | 2.93B | -6.38% | 1,651,416 | 56.99M |
| 201 | GRAL | GRAIL, Inc. | 2.88B | - | 410,940 | 156.12M |
| 202 | PRVA | Privia Health Group, Inc. | 2.87B | - | 644,658 | 2.25B |
| 203 | DYN | Dyne Therapeutics, Inc. | 2.87B | - | 1,448,069 | - |
| 204 | LFST | LifeStance Health Group, Inc. | 2.87B | - | 3,233,866 | 1.49B |
| 205 | BEAM | Beam Therapeutics Inc. | 2.85B | - | 1,327,424 | 164.01M |
| 206 | ALMS | Alumis Inc. | 2.81B | - | 567,311 | 8.40M |
| 207 | SUPN | Supernus Pharmaceuticals, Inc. | 2.80B | - | 526,839 | 776.83M |
| 208 | GPCR | Structure Therapeutics Inc. | 2.79B | - | 732,993 | - |
| 209 | KLRA | Kailera Therapeutics, Inc. | 2.74B | - | 341,295 | - |
| 210 | TARS | Tarsus Pharmaceuticals, Inc. | 2.68B | - | 259,588 | 535.08M |
| 211 | ARQT | Arcutis Biotherapeutics, Inc. | 2.61B | - | 1,163,046 | 415.62M |
| 212 | IDYA | IDEAYA Biosciences, Inc. | 2.56B | - | 450,525 | 225.27M |
| 213 | IRON | Disc Medicine, Inc. | 2.55B | - | 342,496 | - |
| 214 | HTFL | HeartFlow, Inc. | 2.54B | - | 838,955 | 191.42M |
| 215 | ELVN | Enliven Therapeutics, Inc. | 2.53B | - | 632,207 | - |
| 216 | MLYS | Mineralys Therapeutics, Inc. | 2.46B | - | 786,961 | - |
| 217 | GMRS | GMR Solutions Inc. | 2.46B | - | 1,027,357 | 5.74B |
| 218 | DFTX | Definium Therapeutics, Inc. | 2.45B | -0.66% | 1,277,769 | - |
| 219 | IMNM | Immunome, Inc. | 2.45B | - | 1,027,330 | 4.02M |
| 220 | VERA | Vera Therapeutics, Inc. | 2.44B | - | 448,618 | - |
| 221 | GRDN | Guardian Pharmacy Services, Inc. | 2.44B | - | 284,402 | 1.46B |
| 222 | CLDX | Celldex Therapeutics, Inc. | 2.41B | - | 582,927 | 865.00K |
| 223 | TMDX | TransMedics Group, Inc. | 2.38B | -0.01% | 1,152,218 | 635.89M |
| 224 | RARE | Ultragenyx Pharmaceutical Inc. | 2.30B | - | 1,130,551 | 670.00M |
| 225 | PBH | Prestige Consumer Healthcare Inc. | 2.27B | - | 947,407 | 1.09B |
| 226 | KOD | Kodiak Sciences Inc. | 2.26B | - | 500,640 | - |
| 227 | NKTR | Nektar Therapeutics | 2.25B | - | 548,015 | 55.63M |
| 228 | LMAT | LeMaitre Vascular, Inc. | 2.23B | - | 207,218 | 256.28M |
| 229 | ADPT | Adaptive Biotechnologies Corporation | 2.22B | - | 1,235,006 | 295.41M |
| 230 | AXGN | Axogen, Inc. | 2.17B | - | 515,572 | 238.11M |
| 231 | ACHC | Acadia Healthcare Company, Inc. | 2.13B | - | 2,551,850 | 3.37B |
| 232 | ESTA | Establishment Labs Holdings Inc. | 2.12B | - | 273,939 | 229.58M |
| 233 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.11B | - | 4,165,156 | 885.72M |
| 234 | ZLAB | Zai Lab Limited | 2.09B | -2.57% | 390,060 | 453.28M |
| 235 | NVCR | NovoCure Limited | 2.08B | - | 848,887 | 674.41M |
| 236 | NBTX | Nanobiotix S.A. | 2.07B | - | 54,866 | 38.27M |
| 237 | PHVS | Pharvaris N.V. | 2.07B | - | 291,071 | - |
| 238 | HCM | HUTCHMED (China) Limited | 2.05B | - | 51,714 | 548.51M |
| 239 | SEM | Select Medical Holdings Corporation | 2.05B | - | 2,778,227 | 5.52B |
| 240 | XRAY | DENTSPLY SIRONA Inc. | 2.05B | - | 4,784,355 | 3.68B |
| 241 | BHC | Bausch Health Companies Inc. | 2.04B | - | 1,622,366 | 10.53B |
| 242 | OMCL | Omnicell, Inc. | 2.02B | - | 290,233 | 1.23B |
| 243 | TRVI | Trevi Therapeutics, Inc. | 2.01B | - | 1,323,227 | - |
| 244 | MESO | Mesoblast Limited | 1.97B | - | 115,563 | 65.38M |
| 245 | AUPH | Aurinia Pharmaceuticals Inc. | 1.96B | - | 994,131 | 298.30M |
| 246 | PGNY | Progyny, Inc. | 1.95B | - | 1,464,396 | 1.29B |
| 247 | NEOG | Neogen Corporation | 1.94B | - | 4,241,606 | 870.56M |
| 248 | TYRA | Tyra Biosciences, Inc. | 1.93B | - | 312,023 | - |
| 249 | ADMA | ADMA Biologics, Inc. | 1.91B | - | 2,973,308 | 509.86M |
| 250 | VRDN | Viridian Therapeutics, Inc. | 1.90B | - | 2,799,310 | 70.92M |
| 251 | ASTH | Astrana Health, Inc. | 1.88B | - | 375,998 | 3.53B |
| 252 | ZYME | Zymeworks Inc. | 1.87B | - | 477,952 | 81.26M |
| 253 | CLOV | Clover Health Investments, Corp. | 1.87B | - | 4,739,402 | 2.21B |
| 254 | GENB | Generate Biomedicines, Inc. | 1.86B | 3.93% | 784,852 | 30.30M |
| 255 | SION | Sionna Therapeutics, Inc. | 1.86B | - | 182,572 | - |
| 256 | AAPG | Ascentage Pharma Group International | 1.85B | - | 8,252 | 82.08M |
| 257 | LKFT | Lakefront Biotherapeutics NV | 1.84B | - | 123,618 | 1.20B |
| 258 | IOVA | Iovance Biotherapeutics, Inc. | 1.84B | 11.08% | 23,101,121 | 285.61M |
| 259 | STOK | Stoke Therapeutics, Inc. | 1.83B | - | 682,772 | 32.08M |
| 260 | NRIX | Nurix Therapeutics, Inc. | 1.81B | - | 1,053,789 | 71.78M |
| 261 | RAPP | Rapport Therapeutics, Inc. | 1.80B | - | 174,250 | 20.00M |
| 262 | OCUL | Ocular Therapeutix, Inc. | 1.80B | - | 2,032,363 | 52.04M |
| 263 | PLSE | Pulse Biosciences, Inc. | 1.79B | - | 250,594 | 751.00K |
| 264 | SRPT | Sarepta Therapeutics, Inc. | 1.77B | - | 1,959,125 | 2.18B |
| 265 | VCEL | Vericel Corporation | 1.77B | - | 383,595 | 292.09M |
| 266 | UFPT | UFP Technologies, Inc. | 1.77B | - | 161,447 | 608.85M |
| 267 | SNDX | Syndax Pharmaceuticals, Inc. | 1.77B | - | 1,146,122 | 217.17M |
| 268 | NTLA | Intellia Therapeutics, Inc. | 1.76B | 1.86% | 3,198,831 | 66.09M |
| 269 | ANIP | ANI Pharmaceuticals, Inc. | 1.75B | - | 562,394 | 923.71M |
| 270 | HRMY | Harmony Biosciences Holdings, Inc. | 1.75B | - | 431,487 | 899.11M |
| 271 | OCS | Oculis Holding AG | 1.74B | - | 487,736 | 1.40M |
| 272 | ANAB | AnaptysBio, Inc. | 1.74B | - | 408,621 | 232.39M |
| 273 | SGRY | Surgery Partners, Inc. | 1.74B | - | 967,748 | 3.34B |
| 274 | SNDA | Sonida Senior Living, Inc. | 1.73B | - | 590,736 | 367.34M |
| 275 | MD | Pediatrix Medical Group, Inc. | 1.70B | - | 768,671 | 1.93B |
| 276 | ADUS | Addus HomeCare Corporation | 1.69B | - | 173,191 | 1.45B |
| 277 | AGIO | Agios Pharmaceuticals, Inc. | 1.67B | - | 874,516 | 66.05M |
| 278 | CAPR | Capricor Therapeutics, Inc. | 1.67B | - | 569,843 | 11.13M |
| 279 | INVA | Innoviva, Inc. | 1.66B | - | 1,187,326 | 420.69M |
| 280 | PRCT | PROCEPT BioRobotics Corporation | 1.65B | - | 1,120,031 | 322.02M |
| 281 | NUVB | Nuvation Bio Inc. | 1.64B | -1.46% | 4,196,790 | 143.05M |
| 282 | PVLA | Palvella Therapeutics, Inc. | 1.63B | - | 146,367 | - |
| 283 | STAA | STAAR Surgical Company | 1.62B | - | 738,729 | 290.38M |
| 284 | RXRX | Recursion Pharmaceuticals, Inc. | 1.60B | -3.22% | 14,023,416 | 66.41M |
| 285 | AVAH | Aveanna Healthcare Holdings Inc. | 1.60B | -4.43% | 1,433,941 | 2.52B |
| 286 | CMPS | COMPASS Pathways plc | 1.59B | - | 3,871,017 | - |
| 287 | GLUE | Monte Rosa Therapeutics, Inc. | 1.59B | - | 906,671 | 42.95M |
| 288 | ABCL | AbCellera Biologics Inc. | 1.59B | 1.17% | 6,466,569 | 79.21M |
| 289 | ATAI | AtaiBeckley Inc. | 1.59B | - | 5,017,510 | 3.49M |
| 290 | TSHA | Taysha Gene Therapies, Inc. | 1.58B | - | 1,656,371 | 7.47M |
| 291 | IMTX | Immatics N.V. | 1.56B | - | 461,705 | 43.00M |
| 292 | DMRA | Damora Therapeutics, Inc. | 1.56B | - | 166,300 | - |
| 293 | PRGO | Perrigo Company plc | 1.55B | -1.15% | 2,283,498 | 4.18B |
| 294 | VIR | Vir Biotechnology, Inc. | 1.55B | - | 1,209,273 | 65.50M |
| 295 | QURE | uniQure N.V. | 1.53B | -2.30% | 680,412 | 18.09M |
| 296 | GHRS | GH Research PLC | 1.52B | - | 351,017 | - |
| 297 | MBX | MBX Biosciences, Inc. | 1.52B | - | 436,084 | - |
| 298 | NVAX | Novavax, Inc. | 1.51B | - | 4,434,612 | 596.34M |
| 299 | PGEN | Precigen, Inc. | 1.51B | - | 1,713,082 | 31.60M |
| 300 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.51B | - | 818,486 | -665.00K |
| 301 | ARDX | Ardelyx, Inc. | 1.51B | -3.78% | 2,321,999 | 427.68M |
| 302 | INBX | Inhibrx Biosciences, Inc. | 1.49B | - | 553,210 | 1.30M |
| 303 | IMCR | Immunocore Holdings plc | 1.47B | - | 689,631 | 412.81M |
| 304 | SLS | SELLAS Life Sciences Group, Inc. | 1.45B | 2.91% | 10,694,192 | - |
| 305 | AGL | agilon health, inc. | 1.44B | - | 336,332 | 5.82B |
| 306 | ATRC | AtriCure, Inc. | 1.43B | - | 499,202 | 552.16M |
| 307 | NNNN | Anbio Biotechnology | 1.43B | - | 37,322 | 8.65M |
| 308 | MAZE | Maze Therapeutics, Inc. | 1.43B | - | 405,303 | 20.00M |
| 309 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | - | 1,565,725 | 114.48M |
| 310 | BCAX | Bicara Therapeutics Inc. | 1.42B | - | 365,780 | - |
| 311 | BHVN | Biohaven Ltd. | 1.42B | - | 1,440,053 | - |
| 312 | URGN | UroGen Pharma Ltd. | 1.41B | - | 364,372 | 140.49M |
| 313 | WGS | GeneDx Holdings Corp. | 1.40B | -0.04% | 1,089,327 | 442.68M |
| 314 | HCSG | Healthcare Services Group, Inc. | 1.40B | - | 506,389 | 1.85B |
| 315 | ENOV | Enovis Corporation | 1.39B | - | 912,138 | 2.28B |
| 316 | AHCO | AdaptHealth Corp. | 1.39B | - | 730,698 | 3.29B |
| 317 | ALMR | Alamar Biosciences, Inc. | 1.39B | - | 260,289 | 87.16M |
| 318 | PAHC | Phibro Animal Health Corporation | 1.35B | - | 252,830 | 1.50B |
| 319 | MLTX | MoonLake Immunotherapeutics | 1.33B | - | 653,757 | - |
| 320 | ARDT | Ardent Health, Inc. | 1.32B | - | 379,672 | 6.43B |
| 321 | AHG | Akso Health Group | 1.31B | - | 5,488 | 14.84M |
| 322 | MPLT | MapLight Therapeutics, Inc. | 1.30B | - | 164,135 | - |
| 323 | SEPN | Septerna, Inc. | 1.28B | - | 347,216 | 72.26M |
| 324 | SVRA | Savara Inc. | 1.27B | - | 668,290 | - |
| 325 | ATEC | Alphatec Holdings, Inc. | 1.27B | - | 1,727,932 | 787.08M |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.26B | - | 240,803 | 83.72M |
| 327 | INSP | Inspire Medical Systems, Inc. | 1.26B | - | 1,382,029 | 915.25M |
| 328 | FTRE | Fortrea Holdings Inc. | 1.25B | - | 924,177 | 2.71B |
| 329 | AVBP | ArriVent BioPharma, Inc. | 1.24B | - | 434,859 | - |
| 330 | HROW | Harrow, Inc. | 1.23B | - | 681,737 | 268.68M |
| 331 | WVE | Wave Life Sciences Ltd. | 1.23B | -0.62% | 2,386,450 | 71.80M |
| 332 | AVLN | Avalyn Pharma Inc. | 1.21B | - | 321,471 | - |
| 333 | NEO | NeoGenomics, Inc. | 1.20B | - | 779,058 | 745.97M |
| 334 | ZBIO | Zenas BioPharma, Inc. | 1.20B | - | 342,238 | 10.00M |
| 335 | OLMA | Olema Pharmaceuticals, Inc. | 1.19B | - | 1,067,377 | - |
| 336 | TDOC | Teladoc Health, Inc. | 1.19B | - | 2,416,483 | 2.51B |
| 337 | PNTG | The Pennant Group, Inc. | 1.18B | - | 182,649 | 1.02B |
| 338 | IRMD | IRADIMED CORPORATION | 1.18B | - | 142,240 | 86.28M |
| 339 | IART | Integra LifeSciences Holdings Corporation | 1.17B | - | 814,609 | 1.64B |
| 340 | BLFS | BioLife Solutions, Inc. | 1.17B | - | 999,937 | 101.66M |
| 341 | BFLY | Butterfly Network, Inc. | 1.17B | - | 3,262,859 | 102.92M |
| 342 | AVNS | Avanos Medical, Inc. | 1.15B | - | 3,552,260 | 715.90M |
| 343 | DBVT | DBV Technologies S.A. | 1.15B | - | 93,032 | 5.74M |
| 344 | COAG | Hemab Therapeutics Holdings, Inc. | 1.14B | - | 135,307 | - |
| 345 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.14B | - | 2,235,694 | 204.73M |
| 346 | AKTS | Aktis Oncology, Inc. | 1.12B | - | 129,761 | 8.28M |
| 347 | IVA | Inventiva S.A. | 1.12B | - | 185,067 | 7.94M |
| 348 | CNMD | CONMED Corporation | 1.12B | - | 368,500 | 1.37B |
| 349 | CDNA | CareDx, Inc. | 1.12B | - | 522,103 | 412.82M |
| 350 | COLL | Collegium Pharmaceutical, Inc. | 1.11B | - | 163,928 | 796.33M |
| 351 | JBIO | Jade Biosciences, Inc. | 1.10B | - | 372,119 | - |
| 352 | AORT | Artivion, Inc. | 1.09B | - | 651,925 | 458.69M |
| 353 | EYPT | EyePoint, Inc. | 1.08B | - | 783,890 | 7.61M |
| 354 | AMN | AMN Healthcare Services, Inc. | 1.07B | - | 1,106,340 | 3.42B |
| 355 | XERS | Xeris Biopharma Holdings, Inc. | 1.07B | - | 1,088,420 | 314.85M |
| 356 | CRVS | Corvus Pharmaceuticals, Inc. | 1.06B | -3.59% | 1,180,566 | - |
| 357 | ALVO | Alvotech | 1.05B | - | 197,599 | 562.04M |
| 358 | MNKD | MannKind Corporation | 1.04B | - | 4,608,165 | 360.78M |
| 359 | EVO | Evotec SE | 1.04B | - | 39,161 | 859.03M |
| 360 | CRON | Cronos Group Inc. | 1.03B | - | 766,914 | 159.54M |
| 361 | TNDM | Tandem Diabetes Care, Inc. | 1.03B | - | 1,989,751 | 1.03B |
| 362 | KURA | Kura Oncology, Inc. | 998.71M | - | 2,488,755 | 71.64M |
| 363 | SDGR | Schrödinger, Inc. | 993.79M | - | 1,322,877 | 254.91M |
| 364 | OMDA | Omada Health, Inc. | 981.49M | - | 560,307 | 283.30M |
| 365 | PHAR | Pharming Group N.V. | 978.85M | -1.64% | 25,524 | 369.49M |
| 366 | INNV | InnovAge Holding Corp. | 977.30M | - | 247,538 | 949.17M |
| 367 | LXRX | Lexicon Pharmaceuticals, Inc. | 959.26M | - | 1,625,337 | 69.64M |
| 368 | OPK | OPKO Health, Inc. | 958.97M | - | 3,157,365 | 581.12M |
| 369 | USPH | U.S. Physical Therapy, Inc. | 942.96M | - | 140,014 | 787.69M |
| 370 | AZTA | Azenta, Inc. | 930.15M | - | 1,087,753 | 596.48M |
| 371 | SPTX | Seaport Therapeutics, Inc. | 927.99M | - | 214,579 | - |
| 372 | AVR | Anteris Technologies Global Corp. | 925.77M | - | 2,347,248 | 1.85M |
| 373 | PCRX | Pacira BioSciences, Inc. | 918.77M | - | 857,902 | 734.86M |
| 374 | DRTS | Alpha Tau Medical Ltd. | 905.37M | - | 857,991 | - |
| 375 | PHAT | Phathom Pharmaceuticals, Inc. | 899.94M | - | 759,741 | 204.89M |
| 376 | GDRX | GoodRx Holdings, Inc. | 897.49M | - | 1,175,229 | 787.89M |
| 377 | ETON | Eton Pharmaceuticals, Inc. | 892.72M | - | 524,025 | 86.93M |
| 378 | PSNL | Personalis, Inc. | 886.99M | - | 2,691,032 | 64.52M |
| 379 | JANX | Janux Therapeutics, Inc. | 885.49M | - | 436,399 | 13.73M |
| 380 | TALK | Talkspace, Inc. | 871.07M | - | 1,009,829 | 238.37M |
| 381 | INMD | InMode Ltd. | 870.55M | - | 1,265,424 | 374.64M |
| 382 | ANNX | Annexon, Inc. | 870.00M | - | 2,180,186 | - |
| 383 | ORIC | ORIC Pharmaceuticals, Inc. | 861.27M | - | 795,218 | - |
| 384 | AVTX | Avalo Therapeutics, Inc. | 859.45M | - | 1,317,318 | 59.00K |
| 385 | ABUS | Arbutus Biopharma Corporation | 859.29M | - | 847,356 | 191.45M |
| 386 | MGTX | MeiraGTx Holdings plc | 855.71M | - | 383,928 | 79.76M |
| 387 | SANA | Sana Biotechnology, Inc. | 854.36M | - | 4,191,412 | - |
| 388 | CGEM | Cullinan Therapeutics, Inc. | 850.58M | - | 471,167 | - |
| 389 | TBPH | Theravance Biopharma, Inc. | 843.92M | - | 277,610 | 109.78M |
| 390 | XNCR | Xencor, Inc. | 838.54M | - | 522,184 | 97.36M |
| 391 | AURA | Aura Biosciences, Inc. | 838.28M | - | 278,176 | - |
| 392 | OMER | Omeros Corporation | 829.42M | - | 1,525,924 | 9.89M |
| 393 | ODTX | Odyssey Therapeutics, Inc. | 825.55M | - | 323,581 | 2.98M |
| 394 | DRUG | Bright Minds Biosciences Inc. | 825.09M | - | 281,059 | - |
| 395 | EVMN | Evommune, Inc. | 823.74M | - | 376,664 | 10.00M |
| 396 | GERN | Geron Corporation | 821.15M | - | 6,867,345 | 196.12M |
| 397 | CTMX | CytomX Therapeutics, Inc. | 818.56M | - | 2,047,267 | 35.54M |
| 398 | NUTX | Nutex Health Inc. | 818.26M | - | 91,394 | 879.95M |
| 399 | CERT | Certara, Inc. | 815.16M | - | 3,820,987 | 419.75M |
| 400 | AMPH | Amphastar Pharmaceuticals, Inc. | 811.75M | - | 485,197 | 720.53M |
| 401 | QDEL | QuidelOrtho Corporation | 808.75M | - | 1,280,011 | 2.66B |
| 402 | LBRX | LB Pharmaceuticals Inc | 806.39M | - | 145,378 | - |
| 403 | ESPR | Esperion Therapeutics, Inc. | 805.76M | - | 6,695,117 | 418.24M |
| 404 | ABSI | Absci Corporation | 795.12M | - | 2,242,864 | 1.84M |
| 405 | SPRY | ARS Pharmaceuticals, Inc. | 788.47M | - | 2,486,016 | 98.99M |
| 406 | SSII | SS Innovations International, Inc. | 777.77M | - | 54,814 | 48.47M |
| 407 | VOR | Vor Biopharma Inc. | 776.48M | - | 728,621 | - |
| 408 | BVS | Bioventus Inc. | 775.20M | - | 735,115 | 576.30M |
| 409 | LMRI | Lumexa Imaging Holdings, Inc. | 768.65M | - | 644,293 | 1.03B |
| 410 | ANRO | Alto Neuroscience, Inc. | 743.82M | - | 271,396 | - |
| 411 | RLMD | Relmada Therapeutics, Inc. | 738.41M | - | 668,681 | - |
| 412 | BIOA | BioAge Labs, Inc. | 738.36M | - | 211,180 | 10.32M |
| 413 | TENX | Tenax Therapeutics, Inc. | 714.19M | - | 219,568 | - |
| 414 | CBLL | CeriBell, Inc. | 712.18M | - | 204,297 | 95.07M |
| 415 | SGP | SpyGlass Pharma, Inc. | 696.61M | - | 107,184 | - |
| 416 | HSTM | HealthStream, Inc. | 695.61M | - | 222,886 | 311.78M |
| 417 | ALLO | Allogene Therapeutics, Inc. | 690.31M | - | 4,127,266 | 22.00K |
| 418 | CBIO | Crescent Biopharma, Inc. | 689.17M | - | 140,396 | 11.88M |
| 419 | DSGN | Design Therapeutics, Inc. | 685.15M | - | 1,040,815 | - |
| 420 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 684.92M | - | 747,184 | - |
| 421 | SLDB | Solid Biosciences Inc. | 651.74M | - | 969,308 | - |
| 422 | SIBN | SI-BONE, Inc. | 651.05M | - | 324,771 | 206.22M |
| 423 | IRWD | Ironwood Pharmaceuticals, Inc. | 645.28M | - | 1,936,866 | 361.51M |
| 424 | BWAY | BrainsWay Ltd. | 641.20M | - | 74,754 | 56.22M |
| 425 | ACRS | Aclaris Therapeutics, Inc. | 631.28M | - | 627,706 | 8.37M |
| 426 | TLRY | Tilray Brands, Inc. | 631.01M | - | 2,107,785 | 858.28M |
| 427 | CRMD | CorMedix Inc. | 626.05M | - | 826,229 | 400.05M |
| 428 | IMMX | Immix Biopharma, Inc. | 612.76M | - | 2,528,754 | - |
| 429 | CSTL | Castle Biosciences, Inc. | 611.15M | - | 289,271 | 339.92M |
| 430 | TRAX | First Tracks Biotherapeutics, Inc. | 599.45M | - | 318,536 | - |
| 431 | CABA | Cabaletta Bio, Inc. | 595.15M | - | 2,243,441 | - |
| 432 | ZVRA | Zevra Therapeutics, Inc. | 592.92M | - | 1,364,549 | 122.29M |
| 433 | EIKN | Eikon Therapeutics, Inc. | 590.65M | - | 223,696 | - |
| 434 | ARVN | Arvinas, Inc. | 586.50M | - | 778,422 | 89.40M |
| 435 | CADL | Candel Therapeutics, Inc. | 585.43M | - | 1,588,913 | - |
| 436 | NPCE | NeuroPace, Inc. | 576.87M | - | 172,580 | 99.53M |
| 437 | VALN | Valneva SE | 576.27M | - | 75,714 | 180.25M |
| 438 | AGMB | AgomAb Therapeutics NV | 566.35M | - | 34,113 | - |
| 439 | ALT | Altimmune, Inc. | 563.98M | - | 1,989,306 | 36.00K |
| 440 | TCMD | Tactile Systems Technology, Inc. | 561.65M | - | 168,329 | 343.52M |
| 441 | GYRE | Gyre Therapeutics, Inc. | 553.71M | - | 86,973 | 117.05M |
| 442 | TECX | Tectonic Therapeutic, Inc. | 549.47M | - | 109,612 | - |
| 443 | DNA | Ginkgo Bioworks Holdings, Inc. | 549.38M | - | 875,316 | 151.40M |
| 444 | ASMB | Assembly Biosciences, Inc. | 545.58M | 6.94% | 893,900 | 71.10M |
| 445 | CERS | Cerus Corporation | 543.00M | - | 1,731,989 | 216.56M |
| 446 | PHR | Phreesia, Inc. | 542.01M | - | 1,593,684 | 480.59M |
| 447 | MDXG | MiMedx Group, Inc. | 539.18M | - | 815,625 | 389.42M |
| 448 | RIGL | Rigel Pharmaceuticals, Inc. | 536.75M | - | 183,368 | 299.77M |
| 449 | PRME | Prime Medicine, Inc. | 536.43M | 0.68% | 2,273,263 | 4.03M |
| 450 | SRTA | Strata Critical Medical, Inc. | 530.41M | - | 1,726,165 | 228.58M |
| 451 | PROK | ProKidney Corp. | 528.60M | - | 479,735 | 889.00K |
| 452 | FBRX | Forte Biosciences, Inc. | 527.57M | - | 123,968 | - |
| 453 | BBNX | Beta Bionics, Inc. | 526.72M | - | 1,128,451 | 110.24M |
| 454 | CLYM | Climb Bio, Inc. | 525.45M | - | 454,796 | - |
| 455 | KYTX | Kyverna Therapeutics, Inc. | 524.80M | - | 499,407 | - |
| 456 | XOMA | XOMA Royalty Corporation | 522.33M | - | 124,829 | 48.56M |
| 457 | WGRX | Wellgistics Health, Inc. | 518.82M | 4,900.00% | 268,446 | 14.03M |
| 458 | CTNM | Contineum Therapeutics, Inc. | 518.18M | - | 220,306 | - |
| 459 | CTKB | Cytek Biosciences, Inc. | 517.86M | - | 853,544 | 204.17M |
| 460 | AQST | Aquestive Therapeutics, Inc. | 516.85M | - | 893,169 | 50.27M |
| 461 | PRTA | Prothena Corporation plc | 514.63M | - | 510,854 | 57.94M |
| 462 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 463 | ANGO | AngioDynamics, Inc. | 496.85M | - | 211,466 | 313.73M |
| 464 | FLGT | Fulgent Genetics, Inc. | 485.93M | - | 392,972 | 320.35M |
| 465 | EPRX | Eupraxia Pharmaceuticals Inc. | 484.70M | - | 904,099 | - |
| 466 | ACHV | Achieve Life Sciences, Inc. | 481.47M | - | 816,611 | - |
| 467 | ANL | Adlai Nortye Ltd. | 476.80M | - | 24,219 | 5.00M |
| 468 | KIDS | OrthoPediatrics Corp. | 471.83M | - | 119,451 | 243.30M |
| 469 | STTK | Shattuck Labs, Inc. | 467.75M | - | 338,676 | 1.00M |
| 470 | KMDA | Kamada Ltd. | 464.48M | - | 72,337 | 181.68M |
| 471 | TOI | The Oncology Institute, Inc. | 458.92M | - | 1,292,152 | 545.76M |
| 472 | UPB | Upstream Bio, Inc. | 455.50M | - | 354,423 | 3.32M |
| 473 | WEAV | Weave Communications, Inc. | 454.32M | - | 793,782 | 248.72M |
| 474 | CATX | Perspective Therapeutics, Inc. | 453.90M | 2.84% | 1,717,408 | 618.00K |
| 475 | OCGN | Ocugen, Inc. | 453.62M | -0.74% | 3,936,042 | 4.47M |
| 476 | AUTL | Autolus Therapeutics plc | 452.44M | - | 1,043,463 | 92.62M |
| 477 | FDMT | 4D Molecular Therapeutics, Inc. | 449.58M | - | 504,097 | 88.24M |
| 478 | EVH | Evolent Health, Inc. | 444.30M | - | 2,200,166 | 1.89B |
| 479 | NGNE | Neurogene Inc. | 437.87M | - | 105,385 | 925.00K |
| 480 | SGMT | Sagimet Biosciences Inc. | 437.82M | - | 956,526 | - |
| 481 | FULC | Fulcrum Therapeutics, Inc. | 437.78M | - | 306,212 | 80.00M |
| 482 | EBS | Emergent BioSolutions Inc. | 435.99M | - | 986,684 | 676.80M |
| 483 | OFIX | Orthofix Medical Inc. | 434.53M | - | 834,920 | 825.37M |
| 484 | ADCT | ADC Therapeutics SA | 431.18M | - | 648,500 | 79.18M |
| 485 | NRC | NRC Health | 430.00M | - | 115,758 | 138.64M |
| 486 | PRLD | Prelude Therapeutics Incorporated | 429.47M | - | 241,676 | 16.72M |
| 487 | OVID | Ovid Therapeutics Inc. | 427.40M | - | 1,339,323 | 7.12M |
| 488 | VTVT | vTv Therapeutics Inc. | 426.95M | - | 60,552 | 36.84M |
| 489 | VREX | Varex Imaging Corporation | 424.42M | - | 310,081 | 857.50M |
| 490 | STRO | Sutro Biopharma, Inc. | 423.64M | - | 708,168 | 99.61M |
| 491 | MNPR | Monopar Therapeutics Inc. | 422.83M | - | 92,186 | - |
| 492 | MOBI | Mobia Medical, Inc. | 416.88M | - | 78,499 | 32.04M |
| 493 | CGC | Canopy Growth Corporation | 416.65M | -2.80% | 3,890,119 | 203.04M |
| 494 | ZURA | Zura Bio Limited | 413.68M | - | 510,985 | - |
| 495 | IPSC | Century Therapeutics, Inc. | 407.60M | - | 531,889 | 109.16M |
| 496 | LYEL | Lyell Immunopharma, Inc. | 407.41M | - | 54,336 | 31.00K |
| 497 | ENTA | Enanta Pharmaceuticals, Inc. | 405.64M | - | 141,313 | 69.21M |
| 498 | REPL | Replimune Group, Inc. | 405.43M | - | 2,957,749 | - |
| 499 | CCRN | Cross Country Healthcare, Inc. | 404.66M | - | 736,311 | 1.00B |
| 500 | LAB | Standard BioTools Inc. | 402.08M | - | 1,149,840 | 86.26M |